Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. score tier "Top 90+"、profit streak "≥5 yr"、No report yetで絞り込み:72 match(絞り込みを解除)。

# 銘柄 Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin レポート FY
1 ResMed Inc RMD · 米国株 $31B
99/100 卓越
20.4%low 15.3% 10 yr+ Net cash 58% FY2025
2 Cadence Design Systems Inc CDNS · 米国株 $94B
97/100 卓越
27.5%low 20.3% 10 yr+ Net cash 88% FY2025
3 Check Point Software Technologies Ltd CHKP · 米国株 $13B
97/100 卓越
26.1%low 20.8% 10 yr+ Net cash 88% FY2025
4 AJ Bell plc AJB · LSE $2.9B
97/100 卓越
35.9%low 24.8% 10 yr+ Net cash 100% FY2025
5 Adobe Systems Incorporated ADBE · 米国株 $100B
96/100 卓越
33.0%low 15.7% 10 yr+ 0.0× 87% FY2025
6 Monster Beverage Corp MNST · 米国株 $94B
96/100 卓越
23.0%low 17.0% 10 yr+ Net cash 58% FY2025
7 F5 Networks Inc FFIV · 米国株 $23B
96/100 卓越
21.7%low 13.0% 10 yr+ Net cash 82% FY2025
8 Federated Investors Inc B FHI · 米国株 $4.6B
96/100 卓越
28.6%low 22.9% 10 yr+ Net cash 68% FY2025
9 Visa Inc. Class A V · 米国株 $684B
95/100 卓越
35.7%low 18.2% 10 yr+ 0.1× 81% FY2025
10 Garmin Ltd GRMN · 米国株 $57B
95/100 卓越
17.6%low 14.9% 10 yr+ Net cash 58% FY2025
11 Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760 · 深圳 $27B
95/100 卓越
30.1%low 21.4% 10 yr+ Net cash 64% FY2025
12 Snap-On Inc SNA · 米国株 $21B
95/100 卓越
19.5%low 16.4% 10 yr+ Net cash 50% FY2025
13 Manhattan Associates Inc MANH · 米国株 $11B
95/100 卓越
56.1%low 39.9% 10 yr+ Net cash 54% FY2025
14 Jack Henry & Associates Inc JKHY · 米国株 $11B
95/100 卓越
21.7%low 15.4% 10 yr+ Net cash 42% FY2025
15 Paycom Software, Inc. PAYC · 米国株 $7.6B
95/100 卓越
28.8%low 21.9% 10 yr+ Net cash 84% FY2025
16 WD-40 Company WDFC · 米国株 $3.0B
95/100 卓越
36.0%low 30.2% 10 yr+ 0.1× 54% FY2025
17 National Beverage Corp FIZZ · 米国株 $3.0B
95/100 卓越
41.0%low 28.7% 10 yr+ Net cash 37% FY2026
18 Automatic Data Processing Inc ADP · 米国株 $106B
94/100 卓越
52.2%low 42.5% 10 yr+ 0.2× 47% FY2026
19 Intuit Inc INTU · 米国株 $86B
94/100 卓越
33.7%low 12.6% 10 yr+ 0.1× 82% FY2025
20 Fastenal Company FAST · 米国株 $55B
94/100 卓越
31.0%low 25.8% 10 yr+ 0.0× 47% FY2025
21 Hansoh Pharmaceutical Group Co Ltd 3692 · 香港株 $25B
94/100 卓越
26.3%low 11.4% 10 yr+ Net cash 91% FY2025
22 Games Workshop Group PLC GAW · LSE $8.0B
94/100 卓越
57.4%low 48.6% 10 yr+ Net cash 70% FY2026
23 Rightmove PLC RMV · LSE $4.4B
94/100 卓越
60.0%low 60.0% 10 yr+ Net cash 100% FY2025
24 Exponent Inc EXPO · 米国株 $3.2B
94/100 卓越
26.7%low 22.8% 10 yr+ Net cash 60% FY2025
25 KLA Corporation KLAC · 米国株 $239B
93/100 卓越
55.9%low 44.2% 10 yr+ 0.2× 61% FY2026
26 Kweichow Moutai Co Ltd 600519 · 上海 $236B
93/100 卓越
30.8%low 22.9% 10 yr+ Net cash 90% FY2025
27 Hermes International SCA RMS · パリ $173B
93/100 卓越
24.9%low 18.8% 10 yr+ Net cash 68% FY2025
28 Accenture plc ACN · 米国株 $102B
93/100 卓越
33.4%low 24.6% 10 yr+ Net cash 31% FY2025
29 Infosys Ltd ADR INFY · 米国株 $51B
93/100 卓越
27.5%low 20.1% 10 yr+ Net cash 33% FY2026
30 Corpay Inc CPAY · 米国株 $25B
93/100 卓越
26.1%low 14.7% 10 yr+ 0.3× 78% FY2025
31 Nemetschek AG O.N. NEM · XETRA $7.2B
93/100 卓越
26.3%low 19.4% 10 yr+ 0.2× 53% FY2025
32 MarketAxess Holdings Inc MKTX · 米国株 $5.7B
93/100 卓越
25.1%low 19.7% 10 yr+ Net cash 77% FY2025
33 Shenzhen New Industries Biomedical 300832 · 深圳 $5.3B
93/100 卓越
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
34 Proya Cosmetics Co Ltd Class A 603605 · 上海 $3.3B
93/100 卓越
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
35 ASML Holding NV ADR ASML · 米国株 $626B
92/100 卓越
36.5%low 15.9% 10 yr+ Net cash 49% FY2025
36 Applied Materials Inc AMAT · 米国株 $403B
92/100 卓越
38.9%low 23.8% 10 yr+ Net cash 46% FY2025
37 Roche Holding AG ROG · SW $326B
92/100 卓越
39.6%low 26.1% 10 yr+ 0.5× 72% FY2025
38 NetEase Inc 9999 · 香港株 $85B
92/100 卓越
22.0%low 13.6% 10 yr+ Net cash 57% FY2025
39 Nike Inc NKE · 米国株 $62B
92/100 卓越
33.5%low 19.7% 10 yr+ 0.1× 44% FY2026
40 Deutsche Börse AG DB1 · XETRA $51B
92/100 卓越
18.7%low 16.8% 10 yr+ Net cash 59% FY2025
41 IDEXX Laboratories Inc IDXX · 米国株 $44B
92/100 卓越
58.9%low 55.7% 10 yr+ 0.6× 58% FY2025
42 Foshan Haitian Flavouring and Food Co Ltd 603288 · 上海 $31B
92/100 卓越
26.3%low 17.0% 10 yr+ Net cash 41% FY2025
43 ANTA Sports Products Ltd 2020 · 香港株 $28B
92/100 卓越
23.7%low 19.9% 10 yr+ Net cash 57% FY2025
44 Lululemon Athletica Inc. LULU · 米国株 $13B
92/100 卓越
30.2%low 16.2% 10 yr+ Net cash 56% FY2026
45 Brown-Forman Corporation BF-B · 米国株 $13B
92/100 卓越
35.3%low 17.8% 10 yr+ 0.5× 62% FY2026
46 SEI Investments Company SEIC · 米国株 $12B
92/100 卓越
27.0%low 21.7% 10 yr+ Net cash 60% FY2025
47 FactSet Research Systems Inc FDS · 米国株 $9.4B
92/100 卓越
40.4%low 27.3% 10 yr+ 0.6× 53% FY2025
48 Genpact Limited G · 米国株 $5.1B
92/100 卓越
20.4%low 16.8% 10 yr+ 0.2× 36% FY2025
49 Zhejiang Weixing New Building Materials Co Ltd 002372 · 深圳 $2.0B
92/100 卓越
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
50 Kainos Group PLC KNOS · LSE $1.3B
92/100 卓越
34.4%low 25.8% 10 yr+ Net cash 48% FY2026
51 Microsoft Corporation MSFT · 米国株 $3.5T
91/100 卓越
34.6%low 20.0% 10 yr+ 0.1× 68% FY2026
52 Edwards Lifesciences Corp EW · 米国株 $50B
91/100 卓越
23.4%low 10.4% 10 yr+ Net cash 76% FY2025
53 Paychex Inc PAYX · 米国株 $42B
91/100 卓越
42.6%low 37.2% 10 yr+ 0.9× 71% FY2026
54 Adyen NV ADYEN · アムステルダム $30B
91/100 卓越
23.4%low 18.3% 10 yr+ Net cash 72% FY2025
55 Copart Inc CPRT · 米国株 $27B
91/100 卓越
26.4%low 16.9% 10 yr+ Net cash 45% FY2025
56 Gongniu Group Co Ltd 603195 · 上海 $11B
91/100 卓越
36.5%low 24.2% 10 yr+ Net cash 41% FY2025
57 Smith AO Corporation AOS · 米国株 $8.2B
91/100 卓越
23.4%low 13.5% 10 yr+ Net cash 39% FY2025
58 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · 上海 $5.0B
91/100 卓越
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
59 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · 上海 $3.4B
91/100 卓越
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
60 MONY Group plc MONY · LSE $1.3B
91/100 卓越
37.1%low 25.9% 10 yr+ 0.1× 66% FY2025
61 Barrett Business Services Inc BBSI · 米国株 $959M
91/100 卓越
24.9%low 17.0% 10 yr+ Net cash 21% FY2025
62 Lam Research Corp LRCX · 米国株 $367B
90/100 卓越
48.3%low 24.3% 10 yr+ Net cash 47% FY2026
63 Cintas Corporation CTAS · 米国株 $82B
90/100 卓越
32.2%low 20.9% 10 yr+ 0.5× 47% FY2026
64 Electronic Arts Inc EA · 米国株 $53B
90/100 卓越
18.6%low 10.3% 10 yr+ Net cash 76% FY2026
65 Mettler-Toledo International Inc MTD · 米国株 $29B
90/100 卓越
60.0%low 60.0% 10 yr+ 57% FY2025
66 Evercore Partners Inc EVR · 米国株 $12B
90/100 卓越
28.4%low 13.7% 10 yr+ Net cash 99% FY2025
67 Orion Oyj B ORNBV · HE $12B
90/100 卓越
33.1%low 24.4% 10 yr+ 0.1× 60% FY2025
68 IMI PLC IMI · LSE $8.8B
90/100 卓越
24.4%low 21.3% 10 yr+ 0.5× 45% FY2025
69 Chemed Corp CHE · 米国株 $7.1B
90/100 卓越
29.2%low 18.2% 10 yr+ 0.1× 33% FY2025
70 Howden Joinery Group Plc HWDN · LSE $5.5B
90/100 卓越
32.1%low 20.5% 10 yr+ 0.3× 62% FY2025
71 Ninety One PLC N91 · LSE $2.7B
90/100 卓越
51.3%low 21.9% 10 yr+ Net cash 64% FY2026
72 Hangzhou Robam Appliances Co Ltd 002508 · 深圳 $2.1B
90/100 卓越
19.8%low 10.9% 10 yr+ Net cash 53% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.